Yeo, Michele https://orcid.org/0000-0002-1669-9261
Chen, Yong https://orcid.org/0000-0001-8824-7187
Jiang, Changyu
Chen, Gang
Wang, Kaiyuan
Chandra, Sharat
Bortsov, Andrey
Lioudyno, Maria
Zeng, Qian
Wang, Peng
Wang, Zilong https://orcid.org/0000-0001-7473-0354
Busciglio, Jorge
Ji, Ru-Rong https://orcid.org/0000-0002-9355-3688
Liedtke, Wolfgang https://orcid.org/0000-0003-4166-5394
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (DE027454)
Duke Department of Anesthesiology.
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS066307)
Additional funders: 1 Michael Ross Haffner Foundation, Charlotte, NC. 2 Duke University Department of Neurology, Durham, NC.
Article History
Received: 20 February 2020
Accepted: 24 September 2021
First Online: 27 October 2021
Competing interests
: W.L. is a full-time employee of Regeneron Pharmaceuticals (Tarrytown, NY). This affiliation (since April 2021) is not related to the content of this study. Also unrelated to this study, he co-founded TRPblue Inc. (Durham, NC) in December 2017. R.-R.J. is a consultant for Boston Scientific and received research support from this company. These activities are unrelated to this study. Beyond these contacts, the authors declare no competing interests.